Pharmacological analysis of the haemodynamic effects of 5-HT(1B/D) receptor agonists in the normotensive rat

British Journal of Pharmacology

Volumn 123, Issue 2, 1998, Pages 205-214

  Pagniez, Fabrice ^a   Valentin, Jean Pierre ^a   Vieu, Sylvie ^a   Colpaert, Francis C ^a   John, Gareth W ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

5 HT(1A) receptors; 5 HT(1B D) receptors; Bradycardia; GR 127935; Hypotension; Rizatriptan; Sumatriptan; WAY 100635; Zolmitriptan

Indexed keywords

ANGIOTENSIN; ATROPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; PENTOBARBITAL; RIZATRIPTAN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B AGONIST; SEROTONIN 1D RECEPTOR; SEROTONIN AGONIST; SUMATRIPTAN; ZOLMITRIPTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DOSE RESPONSE; HEMODYNAMICS; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL ANIMAL; SYMPATHETIC TONE; VAGOTOMY;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; DRUG INTERACTIONS; HEART RATE; HEMODYNAMIC PROCESSES; MALE; OXAZOLES; OXAZOLIDINONES; PARASYMPATHETIC NERVOUS SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SUMATRIPTAN; TRIAZOLES; TRYPTAMINES;

EID: 0031975780     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701593     Document Type: Article

References (45)

1. 1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system. Br. J. Pharmacol., 114, 961-968.
2. 1-like receptor agonist sumatriptan in anesthetized rabbits. Eur. J. Pharmacol., 304, 87-92.
3. CLEMENT, M.E. & MCCALL, R.B. (1990). Studies on the site and mechanism of the sympatholytic action of 8-OH-DPAT. Brain Res., 525, 232-241.
4. CLEMENT, M.E. & MCCALL, R.B. (1992). Evidence that the lateral tegmental field plays an important role in the central sympathoinhibitory action of 8-OH-DPAT. Brain Res., 587, 115-122.
5. 1D antagonists. J. Med. Chem., 37, 2253-2257.
6. 1B receptors mediate potent contractile responses to 5-HT in rat caudal artery. Br. J. Pharmacol., 109, 609-611.
7. 1A receptor antagonist. Br. J. Pharmacol., 112, 109P.
8. 1D receptor antagonist. Br. J. Pharmacol., 118, 85-92.
9. 1B/D receptor ligand, with functional 5-HT receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 423-430.
10. 7 receptor. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 90-99.
11. DEN BOER, M.O., SOMERS, J.A.E. & SAXENA, P.R. (1992). Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig. Br. J. Pharmacol., 107, 577-583.
12. DIXON, R., GILLOTIN, C., GIBBENS, M., POSNER, J. & PECK, R.W. (1997). The pharmacokinetics and effects on blood pressure of multiple doses of the novel anti-migraine drug zolmitriptan (311C90)in healthy volunteers. Br. J. Clin. Pharmacol., 43, 273-281.
13. FERRARI, M.D. & SAXENA, P.R. (1993). Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol. Sci., 14, 129-133.
14. 1A receptor antagonist. Br. J. Pharmacol., 112, 91P.
15. FOZARD, J.R., MIR, A.K & MIDDLEMISS, D.N. (1987). Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmalogical analysis. J. Cardiovasc. Pharmacol., 9, 328-347.
16. 1A receptors with DP-5-CT and sumatriptan in anaesthetized rats. Br. J. Pharmacol., 114, P448.
17. 1D receptor agonist 311C90. Headache, 34, 394-399.
18. 1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Pain, 67, 355-359.
19. GRADIN, K., PETTERSON, A., HEDNER, T. & PERSSON, B. (1985). Acute administration of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), a selective 5-HT receptor agonist in Sprague-Dawley rat and the spontaneously hypertensive rat. J. Neural Transm., 62, 305-319.
20. 1A receptor activation: ventral medullary sites and mechanisms of action in the rat. J. Auton. Nerv. Syst., 42, 177-188.
21. 1-receptor agonist. Br. J. Clin. Pharmacol., 43, 327-328.
22. 1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol., 94, 1123-1132.
23. KING, K.A. & MCCALL, R.B. (1991). The effects of 8-OH-DPAT on medullary 5-HT neurones and sympathetic activity in baroreceptor-denervated animals. Eur. J. Pharmacol., 200, 357-360.
24. 1 agonist, on the systemic, pulmonary and coronary circulation. Circulation, 87, 401-405.
25. 1B/1D receptor partial agonist, 311C90 (zolmitriptan). Br. J. Pharmacol., 121, 157-164.
26. 2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity. J. Pharmacol. Exp. Ther., 242, 1152-1159.
27. 1A receptor agonists. J. Pharmacol. Exp. Ther., 271, 776-781.
28. 1A receptors: potential implications for prophylactic and acute therapy. Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 682-688.
29. 1B/D receptor ligands: an answer from GTPγS binding studies with stably transfected C6-glial cell lines. Neuropharmacology, 36, 499-512.
30. PERRIN, V.L., FARKKILA, M., GOASGUEN, J., DOENICKE, A., BRAND, J. & TFELT-HANSEN, P. (1989). Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalgia, 9 (Suppl 9), 63-72.
31. 1A receptor agonist 8OH-DPAT and ipsapirone have a central hypotensive action that differs from that of clonidine in anesthetized cats. Eur. J. Pharmacol., 138, 179-191.
32. SAXENA, P.R. & VILLALON, C.M. (1990). Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol., 15, (Suppl. 7)S17-S34.
33. SCIBERRAS, D.G., MAJMUDAR, N., BOWMAN, A.J., MASSEY, A., BRADSTREET, T., CLAYTON, R., REED, J., SHADLE, C., GOLDBERG, M.R. & FORD, G.A. (1997a). A study of the effects of MK-462 (rizatriptan), clonidine and sumatriptan on autonomic function. Br. J. Clin. Pharmacol., 43, 535P.
34. 1D agonist. Br. J. Clin. Pharmacol., 43, 49-54.
35. 1B/D receptor agonists in vivo. In Frontiers in Headache Research, ed. Olesen, J. & Tfelt-Hansen, P. Vol. 6, pp. 293-300. Philadelphia, New York: Lippicott Raven Publishers.
36. 7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat. Br. J. Pharmacol., 121, 563-571.
37. 1 binding sites in autonomic areas of the rat dorsomedial medulla oblongata. Synapse, 10, 217-227.
38. 2A/2C receptor antagonists following acute intravenous and oral administration. Meth. Find. Exp. Clin. Pharmacol., 17, 267-271.
39. 1B/D receptor agonists in the anesthetized rat. Cephalalgia, 15 (Suppl 14), 208.
40. VALENTIN, J.P., BESSAC, A.M., MAFFRE, M. & JOHN, G.W. (1996a). Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open chest rat. Eur. J. Pharmacol., 317, 335-342.
41. 1D receptor agonists in the rabbit isolated saphenous vein. Br. J. Pharmacol., 119, 35-42.
42. 1B/D receptor agonists, sumatriptan and naratriptan in anesthetized, open-chest pigs. Cephalalgia, 15 (Suppl 14), 210.
43. 1D receptor subtype. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 550-556.
44. 7 receptor. Br. J. Pharmacol., 120, 1319-1327.
45. 1A receptors. Eur. J. Pharmacol., 149, 213-223.